N-Me-DL-Leu-OH

N-Me-DL-Leu-OH is a leucine-based amino acid derivative in which the amino group is N-methylated, yielding a secondary amide-like amino functionality while retaining a free carboxylic acid. The molecule contains a chiral center at the α-carbon of the leucine skeleton and is supplied as a DL mixture, enabling stereochemical studies where racemic incorporation or resolution workflows are relevant. Side-chain reactivity is dominated by the isobutyl group typical of leucine, while the carboxylic acid supports salt formation and coupling chemistry. The N-methyl substitution modulates typical amino-acid protection and peptide-coupling behavior, making it a useful intermediate for controlled derivatization and for generating N-methylated peptide fragments or related chiral building blocks.

1. Peptide Coupling Chemistry

N-Me-DL-Leu-OH is used in peptide synthesis research and synthetic organic chemistry to access N-methylated leucine residues where the α-amino functionality is already substituted. The retained carboxylic acid and the N-methylated nitrogen enable downstream conversion into activated carboxylic acid derivatives for amide bond formation, supporting peptide building block preparation that reflects N-methyl peptide motifs. The DL stereochemistry can be employed for comparative studies of stereochemical effects on coupling outcomes, conformational preferences, and analytical detectability. N-Me-DL-Leu-OH can also serve as an intermediate for generating N-methylated peptidomimetic fragments that are compatible with standard amino-acid derivatization workflows.

2. Chiral Resolution Studies

N-Me-DL-Leu-OH is relevant to chiral synthesis and process chemistry intermediate development because the α-chiral center is present while the material is provided as a racemate. The combination of a carboxylic acid and N-methylated amino nitrogen supports formation of diastereomeric salts or derivatives with chiral reagents, enabling resolution strategies that target the DL mixture. The leucine side chain provides a recognizable hydrophobic handle for tuning solubility and crystallization behavior during stereochemical separation. The resulting enantiopure or enriched fractions can then be carried forward as chiral amino acid intermediates for stereodefined peptide analog construction and structure-activity relationship studies.

3. Chemical Biology Labeling

N-Me-DL-Leu-OH is applicable to chemical biology and biomolecule modification workflows where amino acid-derived handles are needed for controlled conjugation chemistry. The free carboxylic acid can be transformed into coupling-ready activated esters or amide-forming intermediates, while the N-methylated nitrogen can influence stability and amide formation kinetics relative to primary amino acids. The leucine scaffold supports incorporation into peptide-like probes and can be used to modulate hydrophobicity and conformational constraints in labeled constructs. DL stereochemistry may be exploited in screening contexts where racemic probe libraries are analyzed by LC-MS and stereochemical assignment is performed at the analytical stage.

4. Peptidomimetics And SAR

N-Me-DL-Leu-OH is used in peptidomimetic construction and medicinal chemistry research intermediate preparation to introduce N-methylated leucine units into peptide analogs. The N-methyl substitution creates an amide nitrogen environment that can affect backbone hydrogen-bonding patterns, while the carboxylic acid functionality enables systematic derivatization into coupling partners for sequential assembly. The leucine side chain provides a hydrophobic, sterically defined element that supports structure-activity relationship studies by varying residue identity and backbone substitution patterns. N-Me-DL-Leu-OH can be employed to generate N-methylated fragments used in SAR workflows and in the synthesis of conformationally constrained analogs.

5. Pharmaceutical Intermediate Synthesis

N-Me-DL-Leu-OH is suitable for pharmaceutical manufacturing and fine chemical synthesis routes that require N-methylated amino acid intermediates for downstream assembly of peptide-like or amino-acid-derived structures. The molecule's defined amino acid backbone, free carboxylic acid, and N-methylated nitrogen support manufacturing-friendly conversion into activated intermediates for controlled amide bond formation. DL availability can be handled in process design either by directing racemate incorporation into non-stereospecific scaffolds or by enabling an in-process chiral step when stereodefined material is required later. The compound's structural features align with industrial amino acid derivative preparation strategies used to build complex, protected or partially substituted intermediates for specialty chemical production.

1. The spatiotemporal control of signalling and trafficking of the GLP-1R

2. Myotropic activity of allatostatins in tenebrionid beetles

3. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes